Parkman Healthcare Partners’s Spyre Therapeutics SYRE Stock Holding History

Parkman Healthcare Partners’s Portfolio SYRE Stock Details SYRE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$4.08M	Sell
2025 Q3	$3.36M	Buy